The largest database of trusted experimental protocols

24 protocols using ferrostatin 1

1

Generation and Characterization of ATF3 Knockout Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HT1080 cells expressing ATF3 and empty vector were generated previously [26 (link)]. Retinal pigment epithelial (RPE) cells immortalized with hTERT were obtained from Dr. Todd Waldman [27 (link)]. To generate ATF3-knockout cells, a target sequence (5′-AAAATGATGCTTCAACACCC-3′) spanning the ATF3 start codon was inserted into pSpCas9(BB)-2A-puro, and used to transfect RPE and U2OS cells as described [28 (link)]. ATF3-knockout HCT116 cells were generated using rAAV-mediated homologous recombination as described previously [14 ]. These cells were cultured in media supplemented with 10% fetal bovine serum. We used DMEM for HT1080, RPE, DU145, and U2OS cells, RPMI 1640 for PC3 cells, and McCoy’s 5A for HCT116 cells. Erastin, RSL3, ferrostatin-1, BSO, Z-VAD-FMK, and FIN56 were purchased from Cayman Chemical. N-acetylcysteine (NAC) was purchased from Thermo Fisher Scientific. Other reagents were obtained from Sigma-Aldrich.
+ Open protocol
+ Expand
2

Evaluating Colorectal and Gastric Cancer Cell Death

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HT29 human colorectal carcinoma cell line was purchased from Dainihon Pharmacy Co. (Tokyo, Japan). TMK-1 human gastric carcinoma cells were a gift from Professor Wataru Yasui (Molecular Pathology, Hiroshima University, Hiroshima, Japan), and the CT26 murine colon carcinoma cell line was a gift from Professor I. J. Fidler (MD Anderson Cancer Center, Houston, TX, USA). Cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum at 37 °C in 5% CO2.
BBR (25 μM for 48 h unless otherwise specified, Tokyo Chemical Industry Co., Ltd., Tokyo, Japan), 5-fluorouracil (5-FU), N-acetyl-L-cysteine (NAC 1 mM), rotenone (0.5 μM) (Sigma-Aldrich Inc., St. Louis, MO, USA), malonate (0.5 mM), vitamin E (20 μM) and vitamin C (1000 μM) (Fujifilm-WAKO Chemicals, Osaka, Japan), Z-VAD-FMK (ZVAD, 20 μM) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), ferrostatin-1 (FRS, 2 μM), deferoxamine (DFO, 200 μM) (Cayman Chemicals, Ann Arbor, MI, USA), were purchased from the manufacturers listed.
Cell death was detected using Live-or-Dye™ Fixable Viability staining kit (Cosmobio, Tokyo, Japan). Dead cells were counted by observation of 500 cells. Apoptotic figures were detected by Hoechst 33342 dye (Sigma) apoptotic figures were counted by observation of 500 cells.
+ Open protocol
+ Expand
3

Inhibitors for Cell Signaling Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Trichloroacetic acid was obtained from Sigma-Aldrich (St. Louis, MO, USA). Bafilomycin A1 (#11038), necrostatin-1 (#11658) and ferrostatin-1 (#17729) were obtained from Cayman chemical (Ann Arbor, MI, USA). PD0325901 (#S1036), SB203580 (#S1076), AS1842856 (#S8222), SP600125 (#S1460) and Ac-DEVD-CHO (#S7901) were purchased from Selleck (Plymouth, MI, USA). For preparing stocks for the inhibitors, Ac-DEVD-CHO was dissolved in ultrapure deionized water; the others were dissolved in DMSO purchased from Sigma-Aldrich (St. Louis, MO, USA). The final DMSO concentration in fish medium did not exceed 0.1%.
+ Open protocol
+ Expand
4

Hepatocyte Viability Assay with APAP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepa1 and Huh7 hepatocytes were grown in Dulbecco’s modified Eagle’s medium supplemented with 5% fetal bovine serum (FBS), 100 units mL−1 penicillin, and 100 µg mL−1 streptomycin. Primary hepatocytes were isolated from mice using type II collagenase (Worthington Biochem, Lakewood, NJ), as described.(28 (link)
) Primary hepatocytes were grown on William’s medium E (Sigma) supplemented with 2% FBS, 100 units mL−1 penicillin, and 100 µg mL−1 streptomycin and transduced with β‐galactosidase (β‐gal) or NIK adenoviral vectors. After 12‐14 hours of growth, hepatocytes were treated with APAP for 2‐24 hours in the presence or absence of NAC, ferrostatin‐1 (Item No. 17729, CAS No. 347174‐05‐4; Cayman Chemicals), or liproxstatin‐1 (Item No. 17730 CAS No. 950455‐15‐9, Cayman Chemicals). Hepatocyte viability was measured using colorimetric 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assays (DOT Scientific Inc., Burton, MI).
+ Open protocol
+ Expand
5

Antibody Acquisition and Small Molecule Procurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies were purchased as follows: BIM (C34C5), BCL-XL (54H6), CREB (48H2) and cleaved caspase-3 (5A1E) from Cell Signaling Technology (Danvers, MA, USA); NOXA (114C307.1) from Thermo Fisher Scientific (Waltham, MA, USA); ATF-3 (C-19) and MCL-1 (S-19) from Santa Cruz Biotechnology (Santa Cruz, CA, USA); KLF4 (56CT5.1.6) from Bioss, Inc. (Woburn, MA, USA); α-tubulin (DM1A) and β-actin (AC-74) from Sigma-Aldrich (Tokyo, Japan). APTO-253 was purchased from MedChemExpress, LLC (Monmouth Junction, NJ, USA). Q-VD-OPh, Doxorubicin, etoposide, SP600125, SB203580, PD184352, and U0126 were purchased from Calbiochem (San Diego, CA, USA). Hydroxychloroquine (HCQ), Necrostatin-1 and Ferrostatin-1 were purchased from Cayman Chemical (Ann Arbor, MI, USA).
+ Open protocol
+ Expand
6

Ferroptosis Pathway Modulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
TVB-3664 (FASNi) or the inactive isomer (TVB-2632) were from Sagimet Biosciences (San Mateo, CA). ML162 (#20455) or Ferrostatin-1 (#17729) were from Cayman. ARS-1620 (HY-U00418) and Liproxstatin-1 (HY-12726) were from MedChemExpress. 16:0–18:1 PC (hereafter PC #850457P), Sodium palmitate (#P9767) and N-Acetyl-L-cysteine (#A7250) were from Millipore-Sigma. CellROX™ Green Reagent (#C10444) was from Thermo Fischer Scientific.
+ Open protocol
+ Expand
7

Chemical Compounds for Cell Death Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
1S,3R-RSL3 (referred to as RSL3) (#19288), Ferrostatin-1 (#17729), idebenone (#15475), Deferoxamine (DFO, #14595), Erastin2 (#27087), ML162 (#20455), ZVAD(OMe)-FMK (#27421), Necrostatin-1 (#11658), IKE (Imidazole Ketone Erastin, #27088), Tocopherol (#25985) Auranofin(#15316), Sulfasalazine(#15025) were all purchased from Cayman Chemical. Etoposide (#E1383), chloroquine (#C6628), and sodium selenite (#S5261), were all purchased from Sigma-Aldrich. Blasticidin S HCl (A1113903), Puromycin (A1113803), Hygromycin B (#10687010), SYTOX Green Dead Cell Stain (#34860), and MitoTracker Deep Red FM (M22426) were all purchased from Thermo Fisher Scientific.
+ Open protocol
+ Expand
8

Cell Death Inhibitor Assay in H9c2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the cell death inhibitor assay, H9c2 cells were treated with human recombinant HMGB1 (40 μg/mL, Biolegend, San Diego, CA, USA) for 48 h, with or without the addition of cell death inhibitors. The following inhibitors were utilized: N-acetyl-L-cysteine (NAC, 1 mM, Sigma, St. Louis, MO, USA), Z-VAD-FMK (ZVAD, 20 μM, Santa Cruz Biotechnology, Santa Cruz, CA, USA), ferrostatin-1 (FRS, 2 μM), deferoxamine (DFO, 200 μM, Cayman Chemicals, Ann Arbor, MI, USA), and 4-phenylbutyric acid (4PBA, 200 μM, WAKO). Additionally, chloroquine (100 µM, WAKO) was employed to inhibit autophagy.
+ Open protocol
+ Expand
9

Ferroptosis-associated Compounds Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Erastin, RSL3, ML162, ML210, ferrostatin-1, liproxstatin-1, JAK inhibitor I and ruxolitinib were purchased from Cayman Chemical. Doxorubicin (Adriamycin) HCl and gemcitabine were purchased from Selleckchem. Deferoxamine mesylate salt, L-Glutathione reduced, sulfasalazine, L-Buthionine-sulfoximine, 2-Mercaptoethanol, and SIINFEKL peptide (OVA 257–264) were purchased from Sigma-Aldrich. Recombinant human IFNγ (285-IF) and mouse IFNγ (485-MI) were purchased from R&D. BODIPY 581/591 C11, anti-IFNγ (XMG1.2) and anti-TNFα (MP6-XT22) blocking antibodies were purchased from Thermo Fisher Scientific. Liperfluo was purchased from Dojindo Molecular Technologies. Cyst(e)inase was obtained from the laboratory of Everett Stone and George Georgiou (University of Texas at Austin, TX, USA).
+ Open protocol
+ Expand
10

Compounds Screening for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 96-well plates (Corning 3917, 3125–6250 cells per well) and treated with compounds 24 h after plating. Compounds were purchased from Cayman Chemical with the exception of stearic acid, oleic acid, adrenic acid, linolenic acid, linoleic acid, docosahexaenoic acid, conjugated linoleic acid (16413), bovinic acid, arachidonic acid, Z-VAD-FML, and (+)-α-tocopherol (T3634), which were purchased from Sigma Aldrich. RSL3 was purchased from Selleckchem, catalpic acid, α-calendic acid, β-calendic acid, and β-ESA were obtained from Larodan Fine Chemicals, and punicic acid was purchased from Matreya LLC. Initial aliquots of ferrostatin-1, deferoxamine, and ML162 were generous gifts of the Dixon Lab (Stanford) and additional quantities were purchased from Cayman Chemical. The inhibitor of FSP19 (link) was purchased from ChemBridge Corp. Staurosporine was purchased from LC Sciences. Cell viability was measured using CellTiter-Glo Luminescent Cell Viability Assay (Promega) according to the manufacturer’s instructions. Luminescence was measured on an EnSpire Alpha (Perkin Elmer) using the integrated software package. Data were normalized to vehicle-treated or sensitizing agent-alone controls and IC50 curves were produced with GraphPad Prism (Version 8).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!